American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting

November 10, 2016

(WASHINGTON, Nov. 10, 2016) - The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting December 3-6 in San Diego.

"I am delighted to recognize these talented early-career researchers for their outstanding contributions to the study of hematology," said 2016 ASH President Charles S. Abrams, MD, of the University of Pennsylvania. "These individuals are shining examples of the promise of the next generation of scientists, and I am pleased that ASH provides the opportunity for rising stars to gain recognition by presenting their work in front of thousands of their distinguished colleagues from all over the world."

The 2016 Outstanding Abstract Achievement Award recipients are:

Undergraduate Student
Ryunosuke Saiki
Kyoto University, Kyoto, Japan
NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms
Publication #955

Medical Student
Matthew Hartwell
Icahn School of Medicine at Mount Sinai, New York, NY An Early Biomarker Algorithm Predicts Lethal Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell

Publication #509

Graduate Student
Xiaotian Zhang
Baylor College of Medicine, Houston, TX
High Order Chromatin Structure Regulates Gene Expression in Hematopoietic Stem Cell Self-Renewal and Erythroid

Publication #1033

Resident Physician
Maximilian Witzel, MD
Ludwig-Maximilians-Universität München, Munich, Germany
SWI/SNF Protein SMARCD2 Orchestrates Transcriptional Networks Controlling Hematopoiesis and Neutrophil Granulocytes in
Humans, Mice and Zebrafish

Publication #2

Post-Doctoral Fellow
Ly Vu, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
RNA Binding Protein Syncrip Regulates the Leukemia Stem Cell Program
Publication #739

Giuseppe Bigi Memorial Award

The ASH Giuseppe Bigi Memorial Award was established in 2015 to recognize an Italian trainee (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) based at an Italian institution who has the highest-scoring abstract submitted in the field of hematopoiesis and stem cells. This annual award is made possible by a generous grant from the Giuseppe Bigi Association, named for the late Giuseppe Bigi, MD, a well-known Italian scientist. The 2016 recipient is:

Patrizia Sciancalepore, MD
University of Turin, Turin, Italy
ATP-Binding-Cassette A1 Regulates Extracellular Isopentenyl Pyrophosphate Release and Vγ9Vδ2 T-Cell Activation By Dendritic Cells
Publication #3709

Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis

The Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis was established to recognize the trainee (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) who is the first author and presenter of the highest-scoring abstract submitted to the ASH Annual Meeting in the field of hemostasis and thrombosis. This annual award honoring excellence in hemostasis and thrombosis is made possible by the Mary Rodes Gibson Hemostasis-Thrombosis Foundation to continue the legacy of Mary Rodes Gibson, who suffered from severe, type 3 von Willebrand disease.

This award will be presented during the invited speaker session of the Special Symposium on the Basic Science of Hemostasis and Thrombosis on Monday, December 5, from 4:30 - 6:00 p.m., in Ballroom 20BC in the San Diego Convention Center. The 2016 recipient is:

Ranjeet Kumar Sinha, PhD
The Scripps Research Institute, La Jolla, CA
Novel R41Q- and R46Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for In Vivo Protective Mechanisms of Action for
Activated Protein C (APC) in Sepsis and Stroke

Publication #13

Minority Graduate Student Abstract Achievement Award

Each year, ASH offers merit-based Minority Graduate Student Abstract Achievement Awards to select graduate students to acknowledge their accomplishments and to recruit and retain minority graduate students in the field of hematology through exposure to the ASH Annual Meeting.

The 2016 Minority Graduate Student Abstract Achievement Award recipients are:

Morayo Adebiyi
The University of Texas Health Science Center at Houston, Houston, TX
Sphingosine-1-Phosphate (S1P) Signaling through S1P Receptor 1 (S1PR1) in Macrophage Contributes to Pain in Sickle Cell

Publication #2476

Stephanie N. Christie
Icahn School of Medicine at Mount Sinai, New York, NY
Inhibiting SOX11-DNA Interaction in Mantle Cell Lymphoma
Publication #1840

Briana Fitch
University of California San Francisco, San Francisco, CA
Mechanism of IL-10 Protective Effect in Development of Childhood B Cell Acute Lymphoblastic Leukemia
Publication #4075

Kamira K. Maharaj
University of South Florida, Tampa, FL
Combinatorial Effect of HDAC6i and Ibrutinib Therapy in CLL Murine Model
Modulation of T Cell Compartment in a Preclinical CLL Murine Model By a Selective PI3K Delta Inhibitor, TGR-1202
Publications #2035 and #3236

Katelyn Melgar
University of Cincinnati College of Medicine, Cincinnati, OH
Molecular Analysis and In Vivo Efficacy Studies on a Novel Chemical-Series of FLT3 Inhibitors in Human FLT3-ITD AML
Publication #36

Amanda Mener
Emory University School of Medicine, Atlanta, GA
C3 Modulates RBC Antigen to Negatively Regulate Antibody Response
Publication #22
A complete list of Abstract Achievement Award recipients is available at
The American Society of Hematology (ASH) ( is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

American Society of Hematology

Related Thrombosis Articles from Brightsurf:

Early indications of thrombosis help in preventing postoperative complications
It is well-known that surgeries can be complicated by life-threatening thromboses that are hard to predict and not easy to prevent.

Standalone D-dimer test strategy may simplify diagnosis of deep vein thrombosis
New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy.

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

High risk of deep vein thrombosis and pulmonary embolism in patients with COVID-19
In a systematic review of the worldwide published data on ''Venous thromboembolism (VTE) in COVID-19 patients'', researchers from the Department of Medicine I (MedUni Vienna), provide an in-depth analysis on the risk of VTE in patients hospitalised for COVID-19.

Possible blood-clotting mechanism in COVID-19 found
Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain.

What is cerebral venous thrombosis? study finds blood clot condition on the rise
Cerebral venous thrombosis (CVT) occurs when a blood clot forms in one of the veins in the brain, preventing blood from draining out of the brain.

Late coronary stent thrombosis in patient with COVID-19
This case report describes a patient with COVID-19 who developed late drug-eluting stent thrombosis.

EULAR 2020: Thrombosis risk particularly high for people suffering
People suffering from rheumatoid arthritis with increased disease activity are more often affected by thrombosis.

Venous thrombosis among critically ill patients with COVID-19
A systematic assessment of deep vein thrombosis among patients in an intensive care unit in France with severe COVID-19 is reported in this case series.

Miniature version of human vein allows study of deep vein thrombosis
The Vein-Chip device, a miniaturized version of a large human vein, allowed scientists to study changes in vein wall cells, blood flow and other functions that lead to deep vein thrombosis in humans.

Read More: Thrombosis News and Thrombosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to